Literature DB >> 17005841

Deletions of the endocytic components VPS28 and VPS32 in Candida albicans lead to echinocandin and azole hypersensitivity.

Muriel Cornet1, Claude Gaillardin, Mathias L Richard.   

Abstract

Vps28p and Vps32p act in both the endocytic and the pH signaling pathways in yeasts and are required for Candida albicans virulence. Here, we show that deletions of VPS28 and VPS32 increase the susceptibility of C. albicans to cell wall disruption agents, echinocandin and azole antifungal agents.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17005841      PMCID： PMC1610091          DOI： 10.1128/AAC.00391-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  24 in total

Review 1.  A protein's final ESCRT.

Authors:  Markus Babst
Journal:  Traffic       Date:  2005-01       Impact factor: 6.215

Review 2.  Advances and challenges in management of invasive mycoses.

Authors:  Thomas F Patterson
Journal:  Lancet       Date:  2005 Sep 17-23       Impact factor: 79.321

3.  Candida albicans RIM101 pH response pathway is required for host-pathogen interactions.

Authors:  D Davis; J E Edwards; A P Mitchell; A S Ibrahim
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Deletions of endocytic components VPS28 and VPS32 affect growth at alkaline pH and virulence through both RIM101-dependent and RIM101-independent pathways in Candida albicans.

Authors:  Muriel Cornet; Frédérique Bidard; Patrick Schwarz; Grégory Da Costa; Sylvie Blanchin-Roland; Françoise Dromer; Claude Gaillardin
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  Snf7p, a component of the ESCRT-III protein complex, is an upstream member of the RIM101 pathway in Candida albicans.

Authors:  Amy L Kullas; Mingchun Li; Dana A Davis
Journal:  Eukaryot Cell       Date:  2004-12

6.  National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program.

Authors:  M A Pfaller; R N Jones; S A Messer; M B Edmond; R P Wenzel
Journal:  Diagn Microbiol Infect Dis       Date:  1998-05       Impact factor: 2.803

7.  ESCRT-I components of the endocytic machinery are required for Rim101-dependent ambient pH regulation in the yeast Yarrowia lipolytica.

Authors:  Sylvie Blanchin-Roland; Grégory Da Costa; Claude Gaillardin
Journal:  Microbiology       Date:  2005-11       Impact factor: 2.777

8.  Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.

Authors:  B J Kullberg; J D Sobel; M Ruhnke; P G Pappas; C Viscoli; J H Rex; J D Cleary; E Rubinstein; L W P Church; J M Brown; H T Schlamm; I T Oborska; F Hilton; M R Hodges
Journal:  Lancet       Date:  2005 Oct 22-28       Impact factor: 79.321

9.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Authors:  Raoul Herbrecht; David W Denning; Thomas F Patterson; John E Bennett; Reginald E Greene; Jörg-W Oestmann; Winfried V Kern; Kieren A Marr; Patricia Ribaud; Olivier Lortholary; Richard Sylvester; Robert H Rubin; John R Wingard; Paul Stark; Christine Durand; Denis Caillot; Eckhard Thiel; Pranatharthi H Chandrasekar; Michael R Hodges; Haran T Schlamm; Peter F Troke; Ben de Pauw
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

10.  Multivesicular body-ESCRT components function in pH response regulation in Saccharomyces cerevisiae and Candida albicans.

Authors:  Wenjie Xu; Frank J Smith; Ryan Subaran; Aaron P Mitchell
Journal:  Mol Biol Cell       Date:  2004-09-15       Impact factor: 4.138
View more
  19 in total

1.  The Rim Pathway Mediates Antifungal Tolerance in Candida albicans through Newly Identified Rim101 Transcriptional Targets, Including Hsp90 and Ipt1.

Authors:  Cécile Garnaud; Encar García-Oliver; Yan Wang; Danièle Maubon; Sébastien Bailly; Quentin Despinasse; Morgane Champleboux; Jérôme Govin; Muriel Cornet
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

2.  Trafficking through the late endosome significantly impacts Candida albicans tolerance of the azole antifungals.

Authors:  Arturo Luna-Tapia; Morgan E Kerns; Karen E Eberle; Branko S Jursic; Glen E Palmer
Journal:  Antimicrob Agents Chemother       Date:  2015-02-09       Impact factor: 5.191

Review 3.  pH signaling in human fungal pathogens: a new target for antifungal strategies.

Authors:  Muriel Cornet; Claude Gaillardin
Journal:  Eukaryot Cell       Date:  2014-01-17

4.  Endosomal Trafficking Defects Can Induce Calcium-Dependent Azole Tolerance in Candida albicans.

Authors:  Arturo Luna-Tapia; Hélène Tournu; Tracy L Peters; Glen E Palmer
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

5.  The Candida albicans ESCRT pathway makes Rim101-dependent and -independent contributions to pathogenesis.

Authors:  Julie M Wolf; Diedre J Johnson; David Chmielewski; Dana A Davis
Journal:  Eukaryot Cell       Date:  2010-06-25

Review 6.  The endocytic adaptor proteins of pathogenic fungi: charting new and familiar pathways.

Authors:  Ping Wang; Gui Shen
Journal:  Med Mycol       Date:  2011-01-24       Impact factor: 4.076

7.  Candida albicans AGE3, the ortholog of the S. cerevisiae ARF-GAP-encoding gene GCS1, is required for hyphal growth and drug resistance.

Authors:  Thomas Lettner; Ute Zeidler; Mario Gimona; Michael Hauser; Michael Breitenbach; Arnold Bito
Journal:  PLoS One       Date:  2010-08-05       Impact factor: 3.240

8.  Candida albicans VPS1 contributes to protease secretion, filamentation, and biofilm formation.

Authors:  Stella M Bernardo; Zachary Khalique; John Kot; Jason K Jones; Samuel A Lee
Journal:  Fungal Genet Biol       Date:  2008-01-26       Impact factor: 3.495

9.  The Ssk1p response regulator and Chk1p histidine kinase mutants of Candida albicans are hypersensitive to fluconazole and voriconazole.

Authors:  Neeraj Chauhan; Michael Kruppa; Richard Calderone
Journal:  Antimicrob Agents Chemother       Date:  2007-07-30       Impact factor: 5.191

10.  A phenotypic profile of the Candida albicans regulatory network.

Authors:  Oliver R Homann; Jeanselle Dea; Suzanne M Noble; Alexander D Johnson
Journal:  PLoS Genet       Date:  2009-12-24       Impact factor: 5.917
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.